Drug
Hm30181 Methanesulfonate Monohydrate Plus Paclitaxel
Hm30181 Methanesulfonate Monohydrate Plus Paclitaxel: highest development phase Phase 1, developed by Athenex. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Athenex
Trials
| Drug | Phase | Indication |
|---|---|---|
| HM30181 methanesulfonate monohydrate plus oral paclitaxel capsules NCT04035473 | Phase 1 | Solid Tumor |
Latest
No recent events.
Follow Hm30181 Methanesulfonate Monohydrate Plus Paclitaxel on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.